Live feed
Filing
SC 13D/A
SC 13D/A0001193125-23-270436·Fairmount Funds Management LLC
Schedule 13D ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2023-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-270436
- Form type
- SC 13D/A
- Filer
- Fairmount Funds Management LLC
- CIK
- CIK 1802528
- Filed
- Nov 03, 2023
- Reporting period
- Oct 30, 2023
- Description
- Schedule 13D beneficial ownership